The incidence of cardiovascular events is largely reduced in patients with maximally tolerated drug therapy and lipoprotein apheresis. A single-center experience-Reference-Cited by-同舟云学术

The incidence of cardiovascular events is largely reduced in patients with maximally tolerated drug therapy and lipoprotein apheresis. A single-center experience

Published:2015-05 Issue: Volume:18 Page:268-272
ISSN:1567-5688
Container-title:Atherosclerosis Supplements
language:en
Short-container-title:Atherosclerosis Supplements

Author:

Sampietro T.,Sbrana F.,Bigazzi F.,Ripoli A.,Dal Pino B.,Pasanisi E.M.,Petersen C.,Coceani M.,Luciani R.,Pianelli M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Reference20 articles.

1. Homozygous cutaneo-tendinous forms of hypercholesteremic xanthomatosis in an exemplary familial case. Trial of plasmapheresis as heroic treatment;de Gennes;Bull Mem Soc Med Hop Paris,1967

2. Efficacy criteria and cholesterol targets for LDL apheresis;Thompson;Atherosclerosis,2010

3. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue;Schwartz;J Clin Apher,2013

4. Current view: indications for extracorporeal lipid apheresis treatment;Schettler;Clin Res Cardiol Suppl,2012

5. Lipoprotein apheresis in patients with maximally tolerated lipid lowering therapy, Lp(a)-hyperlipoproteinemia and Progressive cardiovascular disease: prospective observational multicenter study;Leebmann;Circulation,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Eve is not Adam” – differences in efficacy, safety and clinical outcomes with lipoprotein apheresis between sexes;Endocrine;2024-02-26

2. Cardiovascular events in patients with familial hypercholesterolemia and hyperlipoproteinaemia (a): Indications for lipoprotein apheresis in Poland;Journal of Clinical Apheresis;2021-01-02

3. Long-term lipoprotein apheresis in the treatment of severe familial hypercholesterolemia refractory to high intensity statin therapy: Three year experience at a lipoprotein apheresis centre;Cardiology Journal;2020-01-22

4. Role of Lipoprotein Apheresis in Cardiovascular Disease Risk Reduction;Blood Purification;2019

5. LDL apheresis improves coronary flow reserve on the left anterior descending artery in patients with familial hypercholesterolemia and chronic ischemic heart disease;Atherosclerosis Supplements;2017-11